DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/g9wchv/nonhodgkin) has announced the addition of the "Non-Hodgkin Lymphoma - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Non-Hodgkin Lymphoma and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Non-Hodgkin Lymphoma Overview
- Therapeutics Development
- Pipeline Products for Non-Hodgkin Lymphoma- Overview
- Pipeline Products for Non-Hodgkin Lymphoma- Comparative Analysis
- Non-Hodgkin Lymphoma- Therapeutics under Development by Companies
- Non-Hodgkin Lymphoma- Therapeutics under Investigation by Universities/Institutes
- Non-Hodgkin Lymphoma- Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Non-Hodgkin Lymphoma- Products under Development by Companies
- Non-Hodgkin Lymphoma- Products under Investigation by Universities/Institutes
- Non-Hodgkin Lymphoma- Companies Involved in Therapeutics Development
Companies Mentioned
- 4SC AG
- AB Science SA
- AbbVie Inc.
- Acetylon Pharmaceuticals, Inc.
- Actelion Ltd
- Actinium Pharmaceuticals, Inc.
- ADC Therapeutics Sarl
- Affimed Therapeutics AG
- Agilvax, Inc.
- Allinky Biopharma
- Altor BioScience Corporation
- Amgen Inc.
- Arbutus Biopharma Corporation
- arGEN-X BV
- Astellas Pharma Inc.
- AstraZeneca Plc
- Atara Biotherapeutics, Inc.
- Bayer AG
- Bellicum Pharmaceuticals, Inc.
- BioAtla, LLC
- BioInvent International AB
- BioLineRx, Ltd.
- Bionovis SA
- BioSight Ltd.
- Biothera, Inc.
- Boehringer Ingelheim GmbH
- Boston Biomedical, Inc.
- Bristol-Myers Squibb Company
- Calimmune, Inc.
- Calithera Biosciences, Inc.
- Celgene Corporation
- Cell Medica Limited
- Celltrion, Inc.
- Cellular Biomedicine Group, Inc.
- Celon Pharma Sp. z o.o.
For more information visit http://www.researchandmarkets.com/research/g9wchv/nonhodgkin
